Down Syndrome Obstructive Sleep Apnea (DOSA)
Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea
Sponsor: Brigham and Women's Hospital
This PHASE2 trial investigates Down Syndrome and Obstructive Sleep Apnea and is currently actively recruiting participants. Brigham and Women's Hospital leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
May 2025 — Present [monthly]
Recruiting PHASE2
-
Mar 2025 — May 2025 [monthly]
Recruiting PHASE2
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Oct 2023 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Children's Hospital Los Angeles
- Children's Hospital Medical Center, Cincinnati
- Children's Hospital of Philadelphia
- Children's Hospital of The King's Daughters
- Rainbow Babies and Children's Hospital
- Seattle Children's Hospital
- University of Michigan
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .